Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

AI and machine learning in drug design at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

28 organizations at Discovery on Target 2026 present work in AI and machine learning in drug design: 18 technology and service providers, 6 drug developers and 4 academic, government and non-profit bodies. Between them they bring 44 presentations to the program. Most represented: Genentech, University of California, San Francisco and Eli Lilly. As of Oct 8, 2026.

All 510 organizations at Discovery on Target 2026 →

Showing 1–11 of 28 organizations

Organization	Discovery on Target 2026 Attendance
Genentech South San Francisco, CA
gene.com Large pharma Biotechnology company and member of the Roche Group, discovering and developing medicines in oncology, immunology and neuroscience.	Talk Mon Sep 28 10:15am–10:45am AI-empowered Early Target Discovery with MARS: Multimodal Platform for Target Prioritization and Modality Selection Symposium: Generative AI/Machine Learning-Driven Drug Design Talk Tue Sep 29 11:05am–11:35am Molecular Basis of CXC Chemokine Receptor 3 Ligand Multispecificity Antibodies Against Challenging Targets Talk Wed Sep 30 12:20pm–12:50pm Template-Driven Scaffolding of SCFFBXO42 Regulates PP2A Degradation Emerging Drug Targets Talk Wed Sep 30 2:05pm–2:35pm Accelerating T Cell Engager Immunotherapy Discovery with High-Throughput Kinetic Multiparametric Platform Antibodies Against Challenging Targets Talk Thu Oct 1 11:50am–12:20pm Discovery of Novel Activators for Lysosome Ion Channel TMEM175, a Parkinson's-Disease Target Emerging Drug Targets Talk Thu Oct 1 4:05pm–4:35pm Using Metal Ions to Identify Novel PPI Binding Sites Lead Generation Strategies Talk Thu Oct 1 4:35pm–5:05pm Mechanistic Insights into Hit-Selection Based on DEL Screening Lead Generation Strategies
University of California, San Francisco San Francisco, CA
	Panel Mon Sep 28 5:00pm–6:00pm Where and How Can Open Source AI/ML Learning Impact Drug Development? Symposium: Generative AI/Machine Learning-Driven Drug Design · with PsiThera, Ginkgo Bioworks, Eli Lilly +3 more Talk Tue Sep 29 10:35am–11:35am Ninhydrin as a Covalent Warhead-Targeting Arginine Lead Generation Strategies Talk Tue Sep 29 11:35am–12:05pm Snapshots of the Cell Surface: Mapping Protein Neighborhoods Using Contact-dependent Antibody Mapping (contactMAP) Antibodies Against Challenging Targets Talk Wed Sep 30 11:50am–12:20pm Targeted Degradation of Extracellular Proteins via Induced Shedding Novel Drug Modalities Talk Wed Sep 30 12:20pm–12:50pm Making "n=1" Therapies Accessible for All with Computational Target Prediction Innovative Discovery Technologies Talk Thu Oct 1 10:05am–10:35am Structure-Guided Engineering of a Conformation-Specific Antibody–Drug Conjugate for AML Antibodies Against Challenging Targets Talk Thu Oct 1 10:35am–11:05am Chemical Strategies to Expand the Therapeutic Window for Targeted Radiotherapy Radioligand Therapies
Eli Lilly Indianapolis, IN
lilly.com Large pharma Global pharmaceutical company with medicines in diabetes, obesity, oncology, immunology and neuroscience.	Talk Mon Sep 28 9:45am–10:15am Lilly TuneLab: Applying Federated Learning in Drug Discovery Symposium: Generative AI/Machine Learning-Driven Drug Design Panel Mon Sep 28 5:00pm–6:00pm Where and How Can Open Source AI/ML Learning Impact Drug Development? Symposium: Generative AI/Machine Learning-Driven Drug Design · with PsiThera, Ginkgo Bioworks, Inductive Bio +3 more Talk Wed Sep 30 10:50am–11:05am POSTER SPOTLIGHT: Development of a Novel Platform for Directed Protein Evolution Lead Generation Strategies
X-Chem Waltham, MA	◆Corporate Sponsor
x-chemrx.com CROs & CDMOsCorporate Sponsor Runs DNA-encoded library screening for drug developers, adding machine learning and medicinal chemistry to turn hits into leads.	Booth Exhibiting at Booth 304 Tue, Sep 293:50pm–7:00pmWed, Sep 3011:05am–4:50pmThu, Oct 111:05am–2:15pm Talk Tue Sep 29 12:05pm–12:35pm The Levels of DEL: How Library Chemistry Leads to Clinical Candidates Lead Generation Strategies Talk Wed Sep 30 10:35am–11:05am Chemomics-Driven Drug Discovery with ML and DEL Innovative Discovery Technologies
University of Pennsylvania Philadelphia, PA
	Talk Mon Sep 28 1:35pm–2:05pm Multi-Objective Peptide Design for Programmable Therapeutics Symposium: Generative AI/Machine Learning-Driven Drug Design Talk Wed Sep 30 2:05pm–2:35pm RNA Therapeutic Targeting in a MASH Patient Liver-Derived 3D Fibrosis Microphysiological System Innovative Discovery Technologies
Atombeat	◆Corporate Sponsor
atombeat.com Software & AICorporate Sponsor DP Technology's computational drug discovery brand: free energy perturbation software, AI agents, patent intelligence and CADD services.	Talk Tue Sep 29 12:05pm–12:35pm Physics Meets Agentic AI: Integrating FEP and Patent Intelligence Innovative Discovery Technologies
OpenFold
openfold.io Gov/NGO Non-profit consortium of companies and academic groups building open-source AI models for biomolecular structure prediction, such as OpenFold3.	Chair Mon Sep 28 9:10am–9:15am Chairperson's Remarks Symposium: Generative AI/Machine Learning-Driven Drug Design Talk Mon Sep 28 4:00pm–4:30pm From Consortium to Code: Developing OpenFold3 Symposium: Generative AI/Machine Learning-Driven Drug Design Panel Mon Sep 28 5:00pm–6:00pm Where and How Can Open Source AI/ML Learning Impact Drug Development? Symposium: Generative AI/Machine Learning-Driven Drug Design · with PsiThera, Ginkgo Bioworks, Eli Lilly +3 more
Inductive Bio	◆Corporate Sponsor
inductive.bio Software & AICorporate Sponsor AI company offering machine-learning ADMET prediction models, chemistry software and high-throughput ADME assays to medicinal chemistry teams.	Booth Exhibiting at Booth 428 Tue, Sep 293:50pm–7:00pmWed, Sep 3011:05am–4:50pmThu, Oct 111:05am–2:15pm Talk Mon Sep 28 11:15am–11:30am From Models to Decisions: A Framework for Integrating AI Throughout Design Cycles to Guide Small Molecule Drug Discovery Programs Symposium: Generative AI/Machine Learning-Driven Drug Design Panel Mon Sep 28 5:00pm–6:00pm Where and How Can Open Source AI/ML Learning Impact Drug Development? Symposium: Generative AI/Machine Learning-Driven Drug Design · with PsiThera, Ginkgo Bioworks, Eli Lilly +3 more
Generate Biomedicines Somerville, MA
generatebiomedicines.com Biotech Biotech using generative AI to design protein therapeutics, with antibody programs in clinical development.	Chair Mon Sep 28 1:30pm–1:35pm Chairperson's Remarks Symposium: Generative AI/Machine Learning-Driven Drug Design Talk Mon Sep 28 3:05pm–3:35pm From Proteins as Code to Programmable Therapeutics Symposium: Generative AI/Machine Learning-Driven Drug Design
Ginkgo Bioworks Boston, MA
ginkgobioworks.com CROs & CDMOs Synthetic biology company offering cell engineering, lab automation and, through Ginkgo Datapoints, large-scale biological data generation for AI.	Talk Mon Sep 28 11:30am–11:45am AI Won’t Change Drug Discovery Unless We Change Drug Discovery For AI Symposium: Generative AI/Machine Learning-Driven Drug Design Panel Mon Sep 28 5:00pm–6:00pm Where and How Can Open Source AI/ML Learning Impact Drug Development? Symposium: Generative AI/Machine Learning-Driven Drug Design · with PsiThera, Eli Lilly, Inductive Bio +3 more
Insilico Medicine
insilico.com Biotech AI-driven drug discovery company that sells generative chemistry and target discovery software and runs its own clinical pipeline.	Talk Mon Sep 28 10:45am–11:15am From Model Validation to Clinical Translation: Closing the Gap in AI-Driven Drug Discovery Symposium: Generative AI/Machine Learning-Driven Drug Design Panel Thu Oct 1 9:35am–11:05am Bridging AI/ML Tools and Real-World Drug Discovery Innovative Discovery Technologies · with University of Liverpool, Amazon Web Services, NVIDIA +3 more